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Abstract
Background: Epidemiologic data on malaria are scant in many high-burden countries including the Democratic Republic of
the Congo (DRC), which suffers the second-highest global burden of malaria. Malaria control efforts in regions with
challenging infrastructure require reproducible and efficient surveillance. We employed new high-throughput molecular
testing to characterize the state of malaria control in the DRC and estimate childhood mortality attributable to excess
malaria transmission.
Methods and Findings: The Demographic and Health Survey was a cross-sectional, population-based cluster household
survey of adults aged 15–59 years in 2007 employing structured questionnaires and dried blood spot collection. Parasitemia
was detected by real-time PCR, and survey responses measured adoption of malaria control measures and under-5 health
indices. The response rate was 99% at the household level, and 8,886 households were surveyed in 300 clusters; from 8,838
respondents molecular results were available. The overall prevalence of parasitemia was 33.5% (95% confidence interval
[C.I.] 32–34.9); P. falciparum was the most prevalent species, either as monoinfection (90.4%; 95% C.I. 88.8–92.1) or
combined with P. malariae (4.9%; 95% C.I. 3.7–5.9) or P. ovale (0.6%; 95% C.I. 0.1–0.9). Only 7.7% (95% CI 6.8–8.6) of
households with children under 5 owned an insecticide-treated bednet (ITN), and only 6.8% (95% CI 6.1–7.5) of under-fives
slept under an ITN the preceding night. The overall under-5 mortality rate was 147 deaths per 1,000 live births (95% C.I. 141–
153) and between clusters was associated with increased P. falciparum prevalence; based on the population attributable
fraction, 26,488 yearly under-5 deaths were attributable to excess malaria transmission.
Conclusions: Adult P. falciparum prevalence is substantial in the DRC and is associated with under-5 mortality. Molecular
testing offers a new, generalizable, and efficient approach to characterizing malaria endemicity in underserved countries.
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Introduction
Renewed interest in the eradication of Plasmodium falciparum
malaria has galvanized efforts to define its spatial epidemiology,
which can guide the allocation of resources to areas in greatest
need [1], and facilitate evaluation of the effectiveness of control
[2]. To this end, several countries have recently generated
accurate maps through dedicated Malaria Indicator Surveys
[3,4], and the Malaria Atlas Project (MAP) has meta-analyzed
extant parasite prevalence surveys to produce global estimates of
P. falciparum transmission intensity [5]. Though valuable, such data
may be biased both by measurement error and by incomplete
global coverage of populations at risk of malaria.
The Democratic Republic of the Congo (DRC) accounts for an
estimated 11% of cases of P. falciparum malaria in sub-Saharan
Africa but there is a paucity of clinical and epidemiologic data [6].
Of high-transmission countries, the MAP data search identified
the fewest parasite surveys per land area in the DRC [7], and
current data provide little insight into regional variations in
transmission intensity [8]. At this time, our understanding of the
spatial epidemiology of malaria in the DRC amounts to European
cartographers’ understanding of the African interior in the late
19
th century, when Marlowe, the narrator of Joseph Conrad’s
Heart of Darkness, could remark of what was then the Congo Free
State: ‘‘At that time there were many blank spaces on the earth …
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16420zbut there was one yet – the biggest, the most blank, so to speak –
that I had a hankering after [9].’’
Herein, we endeavor to populate a blank area of the malaria
map by incorporating molecular diagnostics into a nationally-
representative household survey in the DRC. By leveraging the
infrastructure of the Demographic and Health Survey (DHS), we
generate estimates of malaria prevalence, control, and burden in
the DRC. Because this approach represents a new, low-cost, and
generalizable method of robust malaria surveillance, it offers an
opportunity to generate quality malaria epidemiologic data for
countries with challenging infrastructure and thus reduce
disparities in the quality of malaria surveillance between countries.
Results
Survey results and malaria indices
The 8,886 households from 300 clusters surveyed (Figure 1)
yielded data on household-level variables and on 8,992 children
born in the previous 5 years resident in those households.
Additionally, biometric data were available from 8,838 adult
respondents. Survey response rates were 99% for households, 97%
for women and 95% for men. Overall, 51.7% of respondents were
women and 53.8% lived in a rural community.
Malaria control measures targeting children were poorly
deployed (Table 1). Of 5,524 households with children less than
5 years of age, only 7.7% possessed an insecticide-treated bednet
(ITN; cluster median 5%, interquartile range [IQR] 1–15%), and
only 7% of under-fives slept under an ITN the preceding night
(cluster median 4%, IQR 0–13%). Clusters with greater ownership
and utilization of ITNs for under-fives were notable in the west
near Kinshasa and the south near Lubumbashi (Figure 2).
Antimalarials were administered to 24% of children under 5 with
a fever in the preceding two weeks; therapies containing
artemisinin accounted for less than 7%.
Strategies to prevent pregnancy-associated malaria were also
rarely implemented (Table 1). Only 7% of pregnant women
reported sleeping under an ITN the previous night (cluster median
0; IQR 0–20%), and the geographic heterogeneity in ITN use
closely mirrored that of ITN use in under-fives (Figure 2). Under
40% of women who had been pregnant within the previous 5 years
reported receiving any antimalarial during their last pregnancy
(cluster median 40%, IQR 20–60%).
Prevalence of parasitemia
Of 8,838 adult respondents, 2,682 (weighted proportion 33.5%;
95% Confidence Interval [C.I.] 32–34.9) were parasitemic
(Table 1). Among parasitemias, the most prevalent species was
P. falciparum, either as monoinfection (90.4%; 95% C.I. 88.8–92.1)
or as coinfection with P. malariae (4.9%; 95% C.I. 3.7–5.9), P. ovale
(0.6%; 95% C.I. 0.1–0.9), or all three species (0.1%; 95% C.I. 0–
0.3). P. malariae was present in 2.9% (95% C.I. 2.4–3.5) of
Figure 1. Geographic clusters from which households were
selected for sampling.
doi:10.1371/journal.pone.0016420.g001
Table 1. Malaria indices from household survey.
Households with under-5 children (n=5524)
own no bednet 69.1 (67.4–70.8)
own nontreated bednet 23.2 (21.7–24.8)
own ITN 7.7 (6.8–8.6)
Under-5 bednet use (n=7987)
did not sleep under bednet previous night 76.6 (75.3–77.9)
slept under untreated bednet 16.6 (15.5–17.8)
slept under ITN 6.8 (6.1–7.5)
Under-5 clinical illness (n=7934)
recent fever 31 (29.6–32.5)
recent cough 35.5 (34–37.1)
recent diarrhea 16.5 (15.3–17.7)
fever/cough treatment sought (n=3550) 38.5 (36.2–40.8)
diarrhea treatment sought (n=1287) 32.6 (29–36.2)
Under-5 antimalarial treatment for fever (n=770)
Quinine 53.4 (48.1–58.6)
Chloroquine 20.9 (16.9–24.9)
Amodiaquine 16.5 (12.3–20.6)
Fansidar 10.3 (6.3–14.3)
Other antimalarial (including ACTs) 6.4 (4–8.8)
Pregnancy
any antimalarials during last pregnancy (n=5443) 37.8 (35.9–39.6)
pregnant women who slept under ITN previous night
(n=800)
7.4 (4.7–10.1)
Parasitemias (n=8838)
any species 33.5 (32–34.9)
P. falciparum 32.1 (30.7–33.6)
P. malariae 2.9 (2.4–3.5)
P. ovale 0.4 (0.2–0.5)
Proportions weighted to account for sampling design. ITN, insecticide-treated
bednet. HIV, human immunodeficiency virus. ACT, artemisinin-combination
therapy.
doi:10.1371/journal.pone.0016420.t001
DRC Malaria Molecular Epidemiology
PLoS ONE | www.plosone.org 2 January 2011 | Volume 6 | Issue 1 | e16420respondents and 8.7% (95% C.I. 7.1–10.3) of parasitemias. P. ovale
parasitemia was rare overall, as were moninfections with either P.
malariae (1.2%; 95% C.I. 0.7–1.6) or P. ovale (0.1%; 95% C.I. 0.01–
0.2).
There was substantial heterogeneity in parasite rates between
clusters (Figure 3). P. falciparum prevalences were low in the major
cities of Kinshasa, Mbuji-Mayi, Lubumbashi, and Mbadanka, and
in the mountainous eastern regions bordering Rwanda and
Uganda and the southern region bordering Zambia. Clusters
with higher prevalence were marked in rural areas in the interior
and in areas bordering Angola in the south and the Central
African Republic and the Sudan in the north. P. falciparum was
present in 284 of 300 clusters, among which the prevalence of P.
falciparum parasitemia varied from 2.3% to 81.8% (median 31.9%).
P. malariae was present in 143 clusters distributed across the DRC,
and prevalence in these clusters varied from 2% to 16.9% (median
4.3%). P. ovale was present in only 28 clusters, largely in the
interior and southeast.
P. falciparum endemicity and individual and cluster
characteristics
From the lowest to the highest level of P. falciparum endemicity
(as indicated by the prevalence of P. falciparum in adults), the mean
cluster altitude decreased and the proportion of rural communities
increased substantially (Table 2). Additionally, clusters with higher
prevalence tended to have fewer females, be slightly older, and
substantially poorer (all p,0.01). Parasitologically, the prevalence
of P. malariae parasitemias increased with increasing P. falciparum
prevalence (p,0.01).
The penetration of malaria control measures showed mixed
associations with endemicity. However, increasing malaria ende-
micity was associated with increased proportions of fever in
Figure 2. Penetration of malaria control measures. (note difference in visual scales). A. Proportion of households with children under 5 years of
age by cluster who reported owning an insecticide-treated net. B. Proportion of children under 5 years of age by cluster that were reported to have
slept under an insecticide-treated net the night prior to the survey. C. Proportion of pregnant women by cluster who reported sleeping under an
insecticide-treated net the night prior to the survey. D. Proportion of women by cluster who reported taking any antimalarial during their most recent
pregnancy within the preceding 5 years.
doi:10.1371/journal.pone.0016420.g002
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difference in visual scales). A. P. Falciparum.B .P. ovale.C .P. malariae.
doi:10.1371/journal.pone.0016420.g003
Table 2. Individual and cluster characteristics by malaria endemicity.
Cluster P. falciparum prevalence in adults
0-9.9%
(n=60)
10-24.9%
(n=70)
25-49.9%
(n=104)
$50%
(n=66)
P-value for
trend
Cluster characteristics
Altitude, mean, m 1018 (865–1172) 754 (613–896) 716 (634–798) 658 (541–775) ,0.01
Rural 38.3 (25.9–50.8) 50 (38.1–61.8) 61.5 (52.1–71) 80.3 (70.6–90) ,0.01
Adults
Age, mean, y 29.1 (28.7–29.6) 29.1 (28.7–29.6) 29.9 (29.5–30.3) 30.7 (30.1–31.2) ,0.01
Female sex 54.3 (52.1–56.6) 53.3 (51.2–55.4) 51.1 (49.3–52.8) 48 (45.7–50.4) ,0.01
Wealth index, mean
a 3.9 (3.9–4) 3.5 (3.4–3.5) 2.8 (2.8–2.9) 2.3 (2.2–2.3) ,0.01
P. malariae prevalence
b 1.1 (0.6–1.6) 1.9 (1.4–2.5) 2.9 (2.3–3.5) 3.9 (2.9–4.7) ,0.01
P. ovale prevalence
b 0.2 (0–0.3) 0.2 (0–0.4) 0.4 (0.1–0.6) 0.6 (0.3–1) 0.08
Women who received any antimalarial
during last pregnancy
46.2 (40.4–51.9) 44.2 (37.9–50.3) 36.9 (32.2–41.5) 33 (28.4–37.8) ,0.01
Pregnant women who slept under ITN 18.5 (13–24) 11.4 (6.3–16.6) 13.2 (9.1–17.3) 11.9 (7.1—16.5) 0.22
Children under 5 years old
Household owns ITN 11.4 (8.5–14.4) 10.1 (6.9–13.4) 10.3 (7.1–13.5) 7.9 (4.2–11.5) 0.58
Slept under ITN 9.2 (6.4–12.1) 8.6 (5.7–11.5) 9.6 (6.4–12.7) 7.1 (3.7–10.6) 0.74
Slept under no bednet 66.7 (60–73.1) 73.2 (67.4–79) 73.6 (68.6–78.5) 80.8 (75.8–85.7) 0.01
Recent fever 29.2 (26–32.5) 28.7 (25.8–31.7) 34.6 (31.4–37.8) 34.1 (30.3–38) 0.01
Recent cough 34.5 (31.3–37.6) 32.3 (28.7–35.9) 37.4 (34–40.9) 34.9 (30.4–39.3) 0.23
Recent diarrhea 15.7 (13.8–17.5) 15.5 (13.1–17.9) 16.6 (14.6–18.7) 16.3 (14–18.7) 0.87
Treatment sought for fever/cough 27.4 (23.1–31.7) 25.8 (21.4–30.1) 30.3 (26.5–34.2) 30 (25.2–34.8) 0.4
Treatment sought for diarrhea 37.1 (29.3–45) 41.7 (33.4–50) 35.2 (28.4–42) 28.1 (21–35.2) 0.12
Ever received any vaccination 82.3 (78.1–86.5) 82.7 (77.9–87.5) 78 (73.6–82.4) 76.8 (71.4–82.1) 0.24
Values are expressed as percentages unless otherwise indicated; those in parentheses are 95% confidence intervals. ITN, insecticide-treated bednet.
aQuintiles of 1 (poorest) – 5 (wealthiest) based on household ownership of goods owned and lodging characteristics.
bIncludes mixed-species parasitemias.
doi:10.1371/journal.pone.0016420.t002
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endemicity was not associated with the frequency of other
childhood symptoms, the proportion of children for whom
treatment was sought, or the frequency of the receipt of any type
of childhood vaccination.
Malaria endemicity and under-5 mortality
The overall under-5 mortality rate (U5MR) was 147 deaths per
1,000 live births (95% C.I. 141–153); between clusters, the U5MR
ranged from 0 to 378 (standard deviation77) (Figure 4A). In a linear
regression model, increasing cluster P. falciparum prevalence was
significantly associated with increased U5MR (b=0.086;
R
2=0.0538; 95% C.I. 0.044–0.127) (Figure 4B). Between survey
clusters, malaria endemicity was significantly associated with the
U5MR, with median (IQR) U5MRs of 111 (72–155), 117 (76–181),
148 (99–198), and 165 (110–237) per 1,000 live births in clusters
with parasite prevalences of 0–9.9%, 10–24.9%, 25–49.9%, and
$50%, respectively (p=0.001) (Figure 4C). In other pairwise
correlations, the cluster U5MR was inversely associated with the
frequency of the receipt of any childhood vaccination (p,0.001)
and directly associated with the frequency of recent childhood
diarrhea (p=0.006), fever (p,0.001), and cough (p=0.004).
Among children born in the preceding 5 years, after adjustment
for covariates and compared with children born in clusters with
parasite prevalences of 0–9.9%, children under 5 died more
frequently in clusters with prevalence rates of 10–24.9% (adjusted
OddsRatio[aOR] 1.11;95%C.I 0.82–1.49),25–49.9%(aOR1.38;
95% C.I. 1.05–1.82), and $50% (aOR 1.47; 95% C.I. 1.1–1.98)
(Table 3). Based on these data and the estimate that 3.28 million
births occur in the DRC every year [10], 20.6% of excess under-5
deaths were attributable to malaria in communities with adult
parasite prevalence above 10%. With an estimated 553,529 under-5
deaths occurring every year in the DRC [11], we estimate that over
467,000 occur in areas with increased malaria endemicity. Based on
ourunder-5deathsrates,128,881ofthesedeathsexceedwhatwould
be observed at the lowest endemicity, and thus intense malaria
transmission may be responsible for 26,488 yearly under-5 deaths.
Discussion
High throughput PCR analyses of leftover dried blood spots
enabled us to map and quantify malaria endemicity in the DRC
without the need for a dedicated and complex malaria indicator
survey. Overall, the point prevalence of malaria parasitemia was
over 33% in adults, and parasite prevalence within survey clusters
was associated with traditional determinants of malaria endemicity
and with increased under-5 mortality. These associations confirm
the utility of parasite prevalence as a measure of malaria
endemicity.
To our knowledge, this is the first nationally-representative
malaria survey in sub-Saharan Africa to employ molecular
diagnostics, and the first attempt to describe the epidemiology of
malaria in this geographic area since 1951 [12]. These data add
substantially to current attempts to describe malaria endemicity,
most notably the Malaria Atlas Project (MAP) [5]. Unfortunately,
the MAP produced high levels of uncertainty for prevalence
estimates in the DRC owing to a paucity of data for central Africa
[5], relied on studies that employed microscopy for parasite
detection which routinely underestimates the true parasite rate
[13], and utilized parasite rate surveys which were derived from
data sources up to over 20 years old. Moreover, many highly
malarious countries often lack both any reliable malaria data and
the infrastructure to undertake complex surveillance. Integrating
molecular surveillance into DHS surveys, which have been
Figure 4. Under-5 mortality and malaria endemicity. A. U5MR
(deaths per 1000 live births) by survey cluster. B. Cluster U5MR by adult
P. falciparum prevalence. Black dots represent actual U5MRs, weighted
relative to the number of births in each cluster; black line represents
trend line from an unadjusted linear regression model (R
2=0.0538;
p,0.001) weighted for differences in numbers of births between
clusters (gray area is 95% confidence interval). C. Cluster U5MR by
malaria endemicity category. Boxes represent interquartile range,
midline is median, individual dots are outliers. p=0.001 for overall
comparison of medians by Kruskal-Wallis analysis of variance.
doi:10.1371/journal.pone.0016420.g004
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malaria surveillance to underserved countries.
Our method of parasite detection and mapping offers substantial
advantages compared with existing methods. Molecular assays for
malaria are substantially more sensitive than detection using either
blood smears or rapid diagnostic tests [13] and offer the ability to
more definitively detect mixed-species infections with non-falciparum
species [14]. Furthermore, our approach generates data on the
geographic limits of malaria transmission in a fashion that is both
methodologically reproducible and can reflect changes in malaria
epidemiology over time if incorporated into interval surveys.
Parasite rates have been proposed as benchmarks for renewed
malaria control efforts [15]. Malaria indicator surveys can provide
such data [3,4], but are resource-intensive and unfeasible for many
malaria endemic countries. The incorporation of molecular testing
into the DHS exploits the size, sophistication, and frequency of an
existing effort, and can provide malaria data in less-developed
countries where the malaria burden falls most heavily.
Successful malaria control has been highly dependent on
preventive measures and effective therapy [16,17,18], but the
penetration of these initiatives in the DRC was poor: only 8% of
households with children less than 5 years of age owned
insecticide-treated bednets (ITNs), and less than 7% of children
under 5 slept under an ITN. Interventions to prevent pregnancy-
associated malaria – a major contributor to low-birth weight and
maternal and infant mortality – were similarly limited, with over
60% of women denying the receipt of any antimalarial during
their last pregnancy and only 7% of currently pregnant women
reporting having slept under an ITN the previous night. These
numbers contrast with official policies that have called for the free
distribution of ITNs to children and pregnant women since 2006
and the use of intermittent preventive therapy for malaria during
pregnancy since 2002 [6]. Futhermore, fewer than 7% of children
treated with an antimalarial for fever were administered therapy
containing artemisinin, despite the adoption in 2005 of artesunate-
amodiaquine as first-line recommended therapy [6]; additionally,
there was substantial use of poorly-tolerated (quinine) [19] and
ineffective (sulfadoxine-pyrimethamine) antimalarials [20]. Geo-
graphic parsing of the rates of uptake of recommended control
measures between survey clusters demonstrated substantial
heterogeneity, with penetration generally less successful in less
developed and accessible regions. Though sobering, these
numbers indicate substantial opportunities to improve malaria
control.
The adult parasite rates of 34% overall and 82% in some
clusters concur with previous studies of PCR-detectable parasit-
Table 3. Results of a multilevel model of cluster-level indicators on under-5 deaths.
Adjusted Odds Ratio (95% C.I.) p-value
P. falciparum prevalence
a
0.-9.9% REF —
10-24.9% 1.11 (0.82–1.49) 0.501
25-49.9% 1.38 (1.05–1.82) 0.021
.=50% 1.47 (1.1–1.98) 0.01
Prevalence of vaccination receipt
b
1
st quartile REF —
2
nd quartile 0.76 (0.59–0.99) 0.04
3
rd quartile 0.86 (0.67–1.1) 0.235
4
th quartile 0.47 (0.36–0.63) ,0.001
Diarrhea prevalence
c
1
st quartile REF —
2
nd quartile 1.03 (0.78–1.36) 0.836
3
rd quartile 1.16 (0.88–1.54) 0.287
4
th quartile 1.02 (0.76–1.37) 0.894
Fever prevalence
c
1
st quartile REF —
2
nd quartile 1.02 (0.77–1.35) 0.902
3
rd quartile 1.20 (0.88–1.64) 0.246
4
th quartile 1.13 (0.80–1.59) 0.502
Cough prevalence
c
1
st quartile REF —
2
nd quartile 0.88 (0.65–1.18) 0.38
3
rd quartile 0.97 (0.72–1.31) 0.865
4
th quartile 1.09 (0.78–1.51) 0.616
C.I.: confidence interval. Odds ratios are adjusted for other covariates. 1
st quartile are clusters with the lowest proportion of the indicated variable, 4
th quartile with the
highest proportion of the indicated variable. All children born to female respondents in or since 2003 were included (n=8290).
aProportion of adults in each cluster who were parasitemic with P. falciparum by real-time PCR testing.
bProportion children under 5 in each cluster who had ever received any vaccination for any disease (as reported by the child’s mother).
cProportion of children under 5 in each cluster who had diarrhea, fever, or cough in the preceding two weeks, (as reported by the child’s mother).
doi:10.1371/journal.pone.0016420.t003
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[21,22,23,24,25,26,27,28]. The clinical relevance of these largely
asymptomatic parasitemias in adults is indicated by the association
within survey clusters between P. falciparum prevalence and under-
5 mortality (U5MR). Reducing U5MR is a global public health
priority but progress in the DRC is lacking [29]. At present, more
under-5 children die every year in the DRC than any other
country except Nigeria and India, with deaths principally
attributed to pneumonia (20%), diarrhea (19%), and malaria
(17%) [11]. We estimate that over 27,000 yearly under-5 deaths in
areas with elevated endemicity are attributable to malaria. These
deaths underestimate the total burden of malaria on under-fives in
the DRC, but they suggest that reductions in malaria endemicity
will be accompanied by substantial reductions in child deaths.
Though unmeasured factors may account for these differences
in U5MR between levels of malaria endemicity, we incorporated
covariates that address other major contributors to childhood
mortality – lower respiratory tract infection and diarrhea;
treatment-seeking behavior for fever, cough, and diarrhea; and
the receipt of any vaccination – in order to capture a reasonable
degree of variation in clinical syndromes, health system access, and
public health infrastructure that influence childhood mortality.
Additionally, the association between malaria endemicity and
U5MR may be complicated by the complexity of the relationship
between endemicity and the clinical consequences of malaria
infection [30,31,32]. However, across a range of transmission
levels malaria-specific mortality concentrates in the under-5
population [33].
This report is subject to several additional limitations.
Comparing our results with other prevalence studies is complex
because we measured parasite rates using PCR testing in adults,
while other studies typically measure microscopic parasitemias in
children [34]. However, these parasite rates are associated with
common determinants of malaria transmission (altitude, wealth,
urban and rural residence) and with under-5 mortality, demon-
strating both their utility as an index of endemicity and their public
health significance. Additionally, our estimation of U5MR differs
from others that employ a cohort life table approach. This
approach was not feasible to calculate U5MRs on a relatively
small cluster level, and thus we employed a recently validated,
simplified method of U5MR estimation [35]. We did not explore
the effect of HIV infection on childhood mortality or other indices,
though the prevalence of HIV in adults surveyed in the 2007 DRC
DHS was only 1.3% [36]. Finally, we cannot fully account for
seasonal variation in malaria prevalence, though recent rainfall
was not associated with parasitemia in a multivariate model
(Messina J, manuscript submitted).
The integration of molecular malaria testing Demographic and
Health Surveys offers a cost-effective opportunity to generate
robust data in order to guide the allocation of resources and
measure control initiative effectiveness. Such initiatives are
succeeding in multiple sub-Saharan African settings, including
Kenya [37], the Gambia [16], and Tanzania [17]. Comparatively
less interest and enthusiasm for control efforts have been directed
at highly-endemic countries. This work in the DRC populates a
blank space on the malaria map to inform future efforts to control
malaria and reduce mortality in the most intensely malarious
regions on earth.
Materials and Methods
Ethics statement
All survey respondents provided verbal informed consent for the
collection of blood spots in one of the five main languages spoken
in the DRC per DHS protocol. Consent was verbally acquired
owing to both limited literacy levels in rural provinces as well as
the need for immediate de-identification of all data at the
conclusion of the interview to ensure the confidentiality of the
publicly-accessible survey datasets. Consent procedures, survey
administration, and blood sample collection were approved by the
Ethics Committees of Macro International and the School of
Public Health of the University of Kinshasa, and testing for
malaria parasites was approved by the Institutional Review Board
of the University of North Carolina.
Survey methodology
The 2007 DHS was designed to provide nationally-representa-
tive data on population, health, and social indices for program
planning and impact evaluation. It was the first such survey
conducted in the DRC and represented a collaboration between
the DRC Ministries of Health and Planning and Macro
International, with funding provided by the United States’ Agency
for International Development United Nations, the World Bank,
and the United Kingdom’s Department for International Devel-
opment.
The DHS employed a stratified two-stage cluster design based
on DRC census data obtained before the national election in 2006.
The survey’s sampling units were 300 randomly selected
geographic clusters (Figure 1), from which 9000 households were
selected for inclusion; all women aged 15 to 49 years within these
households were surveyed, and, in half of the households, men
aged 15 to 59 were surveyed. All men and half of the women and
men were consented for collection of blood spots. Three
questionnaires, translated into the four main languages spoken
in the DRC, were employed: for the household, for women, and
for men. The household survey mainly served to identify men and
women for possible individual inclusion, and included basic
household data. Topics in the female questionnaire included birth
history, childhood health indices and vital status, and a malaria
module; the male questionnaire was substantially reduced. The
DHS was conducted in February and March for clusters in and
near Kinshasa, and between May and August for the balance of
the DRC.
Blood spots were collected from adult women and men in half of
the surveyed households, primarily for estimating the seropreva-
lence of HIV. After consent was obtained, blood was collected in
multiple spots on a single filter paper from each participant and
placed in a drying box with desiccant overnight. After transfer to
sealed plastic bags with desiccant and humidity indicators, they
were placed into coolers prior to transport to Kinshasa. From each
card, three 0.3 inch discs were punched and deposited in a single
well of a plastic 96-well sample plate, which, when full, was sealed
with a plastic cover, placed in a sealed plastic bag with desiccant,
and stored at room temperature.
Molecular assays
Plates of punched blood spots were transferred from Kinshasa
to the University of North Carolina, where genomic DNA (gDNA)
was extracted using the invitrogen PureLink 96 Kit (invitrogen,
Carlsbad, CA) using a vacuum manifold. In the final step, gDNA
was eluted using 200 uL of elution buffer into a fresh 96-well
sample plate, and sample plates were sealed securely and stored at
-20C prior to further processing.
Molecular testing employed two real-time PCR assays that
target the 18S ribosomal DNA sequence of Plasmodia. Samples
were initially amplified in a real-time PCR assay that detects all
species of Plasmodia [38], which included 4uL of gDNA in a
25 uL reaction volume. Samples demonstrating amplification in
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that targets species-specific sequences of P. falciparum, P. ovale, and
P. malariae, as well as that of a human control gene [38]; this assay
consisted of two duoplex assays run in parallel, each of 25 uL with
2 uL of gDNA Threshold lines were set manually based on
controls to exclude background fluorescence upon inspection of
the delta Rn plots over 40 cycles; to optimize sensitivity of the
assays, any amplification of target was interpreted as positive.
All reaction plates included negative controls (with molecular-
grade water in place of template) and positive controls: P. falciparum
gDNA for the pan-species assay and mixtures of P. falciparum, P.
ovale, P. malariae, or human DNA for the speciation assay, as
appropriate. The first 867 samples were tested in duplicate;
because of the lack of discordant results, the balance of samples
was tested singly in each assay. For quality control, a random set of
5% of all gDNA samples was retested in the pan-species assay, and
discordant repeat pan-species results were resolved by repeating
the speciation assay. Ultimately, 8 specimens (of 520 re-tested) that
were initially pan-species negative were determined to harbour P.
falciparum after quality control testing. All reactions were
performed on an ABI 7300 System (Applied Biosystems, Foster
City, CA) and analyzed using the ABI 7300 Sequence Detection
Software (v1.3). Reaction plates were prepared using an epMotion
5070 system (eppendorf, Hamburg, Germany). To minimize the
risk of sample contamination, filtered pipet tips were exclusively
employed in all steps, and separate work areas were maintained for
punching discs from blood spots, extracting gDNA, preparing
reaction mixtures, and assembling reaction plates.
In subsequent analyses, malaria parasitemia positivity was
defined as the presence of any species of Plasmodium by both the
pan-species and the speciation real-time PCR assays.
Analyses of survey and malaria data
Population-level proportions of the penetration of malaria
control measures (bednet use among children and pregnant
women, effective antimalarial use, and receipt of antimalarials
during pregnancy), the prevalence of childhood illnesses, and the
prevalence of parasitemias were calculated using sampling weights
to account for survey design. For children born in the preceding 5
years, women were queried whether the child slept under a bednet
the previous night; ever received any vaccination; experienced
fever, cough or diarrhea in the preceding 2 weeks; was
administered treatment for fever, cough, or diarrhea; and was
administered an antimalarial for fever. Additionally, heads of
households were queried about the residence of children under 5
and the possession and type of bednet, and women were queried
about pregnancy status and their personal bednet use.
To analyze geographic variation of the adoption of malaria
control measures in children and pregnant women, cluster-level
indicators were generated. Within each cluster, we calculated the
prevalence of parasitemia with each species and, using survey data,
the cluster-level frequencies of adherence to malaria control
measures among children and pregnant women. Using ArcGIS
(v9.3, ESRI, Redlands, CA, USA), individual maps of parasite
rates and rates of uptake of control measures were generated using
inverse-distance weighting to smooth surfaces across unmeasured
locations between survey clusters. Additionally, we tested the
cluster parasite prevalences by species for spatial autocorrelation
by examining the significance of global Moran’s I values based
upon row-standardized inverse distance weights matrices. Prior to
analysis, cluster coordinate locations were randomly offset by 2
kilometers (in urban clusters) or 5 kilometers (in rural clusters) to
maintain privacy.
To examine associations between malaria endemicity and
cluster-level indicators, the proportion of adults in each cluster
that were parasitemic with P. falciparum served as an index of
malaria endemicity. Clusters were grouped into categories of P.
falciparum prevalence that approximated quartiles: 0–9.9%, 10–
24.9%, 25–49.9%, and $50%. Bivariate associations between
malaria endemicity (the main independent variable) and cluster-
level demographics, adoption of malaria control measures, and
childhood illnesses were assessed with one-way analysis of variance
or the chi-squared test for continuous or categorical outcome
variables, respectively.
Malaria endemicity and childhood mortality
Surveyed women were queried about their total number of
births and about the vital status of all births. From complete birth
histories, the under-5 mortality rate (U5MR) was calculated on
national and cluster levels as the fraction of children ever born to
surveyed women that died prior to 60 months of age. Cluster-level
U5MR was mapped as above. This approach is biased towards
underestimating U5MR because it does not account for the
foreshortened time of exposure among children less than 5 years of
age at the time of survey. Nevertheless, due to the small sample
size at the cluster level, it was deemed a more appropriate method
than the life table technique, and it has been validated as an
accurate estimate compared with more traditional methods [35].
To assess potential confounders of the main effect of malaria
endemicity and U5MR, cluster-level proportions were generated
for prevalence of the receipt of any vaccination (among all live
births); the prevalences of fever, cough, and diarrhea (among all
living children); and the prevalence of medical treatment sought
for fever, cough, or diarrhea (among children with respective
symptoms).
To evaluate the overall influence of malaria endemicity (as
reflected by the cluster P. falciparum prevalence) on cluster U5MR,
linear regression was employed; the independent variable was the
cluster parasite prevalence as a continuous measure and the
dependent variable was the cluster U5MR. Differences in median
U5MR by cluster malaria endemicity (categorized as above) were
compared by the Kruskal-Wallis analysis of variance due to the
non-parametric distribution of cluster U5MRs.
To estimate the population attributable fraction (AFp)o f
parasite prevalence on under-5 mortality, adjusted odds ratios
(aORs) for under-5 death were calculated using logistic regression.
The model incoporated child health covariates that were
significantly associated with U5MR in bivariate testing. Because
the data were clustered and the model included cluster-level
independent variables and an individual-level dependent variable,
a multilevel random-intercept logistic regression model was
employed to account for the potential interdependence of
observations within cluster groups (xtlogit in Stata/IC version
10.0, StataCorp, College Station, TX) [39]. In this model, the
main independent variable was the categorized adult parasite
prevalence within each cluster; the dependent variable was the
death of a child born in the preceding 5 years. As covariates, the
model included cluster-level indicators of the proportion of
children under 5 who had ever received any vaccination and
who had suffered diarrhea, cough, or fever in the preceding two
weeks. Clusters with missing values were excluded from the model.
The AFp for under-5 deaths by each parasite prevalence category
was then estimated using the aORs and the fraction of births
within each parasite prevalence category [40]. This fraction of
births across the DRC as a whole was extrapolated from the
distribution of births within surveyed clusters, assuming that the
survey was nationally-representative.
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All reported p-values are two-sided; a p-value of less than 0.05
was considered appropriate to reject the null hypothesis for each
analysis. Molecular data were imported directly into a FileMaker
Pro database (version 10, FileMaker, Inc, Santa Clara, CA) and
later merged with survey data in Stata/IC; all statistical analyses
were subsequently performed with Stata/IC.
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